‘Breaking Down Barriers to a Personalized Approach to Medications to Reduce Adverse Drug Effects’
HOUSTON, March 22, 2022 /PRNewswire/ — The American Society of Pharmacovigilance (ASP) will virtually address members of the U.S. Congress and their staff on March 29, from 12:30 p.m. to 1:30 p.m. EST, related to ASP’s continuing mission to rapidly and dramatically reduce the high rate of suffering and mortality due to adverse drug events (ADE) – the fourth leading cause of death in the United States. The ASP is a 501(c)(3) nonprofit organization who convenes the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE Initiative) and is a national biomedical and healthcare network with membership open to all healthcare professionals. Those interested in this important congressional briefing may register online.
Featured panelists will explain the basics of ADEs and…
